Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab by Nicoletta Colombo, Domenica Lorusso, Bradley J. Monk, Brian Slomovitz, Kosei Hasegawa, Angélica Nogueira-Rodrigues, Melissa Zale, Chinyere E. Okpara, Gianmaria Barresi, Jodi McKenzie, Vicky Makker

Get full text